Antilymphoma effect of 9-ING-41 in vivo in Jeko-derived xenograft mouse model. (A) Experimental design showing 9-ING-41 treatment schedule and dosage. (B) Bioluminescence images of xenograft-bearing mice that were left untreated or treated with 9-ING-41. The images were taken at the end of the experiment (day 17). The experiment was performed twice; both showed similar results.